Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 10
2004 11
2005 24
2006 15
2007 24
2008 30
2009 38
2010 59
2011 51
2012 56
2013 65
2014 88
2015 86
2016 86
2017 100
2018 131
2019 145
2020 143
2021 156
2022 180
2023 139
2024 147
2025 82

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,638 results

Results by year

Filters applied: . Clear all
Page 1
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
Wu YL, Dziadziuszko R, Ahn JS, Barlesi F, Nishio M, Lee DH, Lee JS, Zhong W, Horinouchi H, Mao W, Hochmair M, de Marinis F, Migliorino MR, Bondarenko I, Lu S, Wang Q, Ochi Lohmann T, Xu T, Cardona A, Ruf T, Noe J, Solomon BJ; ALINA Investigators. Wu YL, et al. Among authors: wang q. N Engl J Med. 2024 Apr 11;390(14):1265-1276. doi: 10.1056/NEJMoa2310532. N Engl J Med. 2024. PMID: 38598794 Clinical Trial.
Organoids.
Zhao Z, Chen X, Dowbaj AM, Sljukic A, Bratlie K, Lin L, Fong ELS, Balachander GM, Chen Z, Soragni A, Huch M, Zeng YA, Wang Q, Yu H. Zhao Z, et al. Among authors: wang q. Nat Rev Methods Primers. 2022;2:94. doi: 10.1038/s43586-022-00174-y. Epub 2022 Dec 1. Nat Rev Methods Primers. 2022. PMID: 37325195 Free PMC article.
Sweetener aspartame aggravates atherosclerosis through insulin-triggered inflammation.
Wu W, Sui W, Chen S, Guo Z, Jing X, Wang X, Wang Q, Yu X, Xiong W, Ji J, Yang L, Zhang Y, Jiang W, Yu G, Liu S, Tao W, Zhao C, Zhang Y, Chen Y, Zhang C, Cao Y. Wu W, et al. Among authors: wang q. Cell Metab. 2025 May 6;37(5):1075-1088.e7. doi: 10.1016/j.cmet.2025.01.006. Epub 2025 Feb 19. Cell Metab. 2025. PMID: 39978336 Free article.
Mechanistic investigations of diabetic ocular surface diseases.
Zhou Q, Yang L, Wang Q, Li Y, Wei C, Xie L. Zhou Q, et al. Among authors: wang q. Front Endocrinol (Lausanne). 2022 Dec 16;13:1079541. doi: 10.3389/fendo.2022.1079541. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36589805 Free PMC article. Review.
Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Updated Analysis From the Phase 3 ADAURA Trial.
John T, Grohé C, Goldman JW, Shepherd FA, de Marinis F, Kato T, Wang Q, Su WC, Choi JH, Sriuranpong V, Melotti B, Fidler MJ, Chen J, Albayaty M, Stachowiak M, Taggart S, Wu YL, Tsuboi M, Herbst RS, Majem M. John T, et al. Among authors: wang q. J Thorac Oncol. 2023 Sep;18(9):1209-1221. doi: 10.1016/j.jtho.2023.05.015. Epub 2023 May 24. J Thorac Oncol. 2023. PMID: 37236398 Free article. Clinical Trial.
1,638 results